UPDATE: Sunesis Reports Schedule C Had Most Favorably Safety/Efficacy Balance

By: via Benzinga
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the publication of results from the Company's REVEAL-1 (Response ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.